1. Home
  2. DNLI vs RNW Comparison

DNLI vs RNW Comparison

Compare DNLI & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • RNW
  • Stock Information
  • Founded
  • DNLI 2013
  • RNW 2011
  • Country
  • DNLI United States
  • RNW United Kingdom
  • Employees
  • DNLI N/A
  • RNW N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • RNW Electric Utilities: Central
  • Sector
  • DNLI Health Care
  • RNW Utilities
  • Exchange
  • DNLI Nasdaq
  • RNW Nasdaq
  • Market Cap
  • DNLI 1.9B
  • RNW 2.2B
  • IPO Year
  • DNLI 2017
  • RNW N/A
  • Fundamental
  • Price
  • DNLI $14.37
  • RNW $6.58
  • Analyst Decision
  • DNLI Strong Buy
  • RNW Strong Buy
  • Analyst Count
  • DNLI 15
  • RNW 1
  • Target Price
  • DNLI $33.92
  • RNW $7.50
  • AVG Volume (30 Days)
  • DNLI 1.4M
  • RNW 707.4K
  • Earning Date
  • DNLI 05-06-2025
  • RNW 06-04-2025
  • Dividend Yield
  • DNLI N/A
  • RNW N/A
  • EPS Growth
  • DNLI N/A
  • RNW N/A
  • EPS
  • DNLI N/A
  • RNW 0.04
  • Revenue
  • DNLI N/A
  • RNW $1,006,524,942.00
  • Revenue This Year
  • DNLI N/A
  • RNW N/A
  • Revenue Next Year
  • DNLI $384.25
  • RNW $38.75
  • P/E Ratio
  • DNLI N/A
  • RNW $167.72
  • Revenue Growth
  • DNLI N/A
  • RNW N/A
  • 52 Week Low
  • DNLI $10.57
  • RNW $5.15
  • 52 Week High
  • DNLI $33.33
  • RNW $7.49
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 46.97
  • RNW 60.27
  • Support Level
  • DNLI $13.36
  • RNW $6.20
  • Resistance Level
  • DNLI $16.97
  • RNW $6.47
  • Average True Range (ATR)
  • DNLI 0.95
  • RNW 0.17
  • MACD
  • DNLI -0.06
  • RNW 0.02
  • Stochastic Oscillator
  • DNLI 28.08
  • RNW 85.33

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

Share on Social Networks: